Outsourced Pharma White Papers

1. Compound Library Consortium 5/16/2024

   Explore how a novel approach to enhancing drug discovery efforts can significantly improve the chances of identifying promising drug candidates, ultimately accelerating the path from discovery to development.

2. EMA Support For Rare Disease Therapies 6/10/2025

   Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.

3. Analytical Techniques For Characterization, Release, And Stability Testing 4/28/2025

   Review the analytical considerations for subunit vaccines, vaccines that contain only the antigenic component(s) of a pathogen, and more specifically the assays needed.

4. Utilizing MAPPs For An Enhanced Assessment Of Immunogenicity 1/4/2024

   Explore how MAPPS demonstrates promise as a valuable tool for comprehensive immunogenicity assessment in therapeutic protein development, contributing to safer and more effective biologics.

5. Future-Proofing Life Sciences Manufacturing: 2025 CDMO Trends 3/12/2025

   Review contract manufacturing's evolution, driven by technological advancements and regulatory changes, and how CMOs and CDMOs are navigating opportunities and challenges.

6. Optimizing DSP Development: Faster Timelines, Lower Costs, And High-Quality Processes 4/8/2025

   The biopharmaceutical industry faces growing downstream processing challenges in purifying complex biologics efficiently and at scale.

7. Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators 4/28/2025

   Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.

8. Assessing A Targeted Molecular Method Against Traditional In Vitro Testing For Adventitious Virus Detection 10/3/2024

   Discover a CHO AOF panel that provides rapid detection of relevant adventitious viral contaminants in bulk harvest material, and explore data showing equivalent sensitivity to the in vitro assay.

9. Establishing Commercial Manufacturing Services For ADCs 6/3/2024

   Explore how one organization built upon 15+ years of experience and an extensive knowledge base of biologics manufacturing to establish commercial-scale ADC manufacturing capabilities.

10. The 5 Ws Of A Human Factors Strategy 3/31/2025

    A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.